According to the DEA, the Federal Register, and Department of Justice materials attached to this article, the current rescheduling process is moving through formal rulemaking rather than an immediate policy switch.
What Is Documented
The published federal materials describe a comment process and a possible hearing window before any final rule takes effect. That means the procedural timeline is real, but the end state is not yet settled.
Federal agencies have presented the timeline as a way to clarify process for regulators, operators, researchers, and other affected stakeholders who have been waiting for the next formal step.
What Is Still Unresolved
The available source record does not by itself guarantee when a final rule will be issued or what the final classification will be after comments, hearings, and interagency review are complete.
That uncertainty matters. State regulators, licensed operators, and medical researchers may view the timeline as progress, but compliance obligations and enforcement priorities still depend on the final federal action, not just the procedural calendar.
Why This Matters
The immediate takeaway is process clarity, not policy finality. Readers should treat this article as a sourced update on federal rulemaking steps, with the underlying DEA and Federal Register materials carrying more weight than any short-term political or market interpretation.